يعرض 1 - 10 نتائج من 134 نتيجة بحث عن '"Tumor Necrosis Factor-alpha/*antagonists & inhibitors"', وقت الاستعلام: 1.60s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المساهمون: ​Robotics and image-guided minimally-invasive surgery (ROBOTICS), Gastroenterology and hepatology, Surgery, AGEM - Digestive immunity, AII - Inflammatory diseases, Graduate School, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Gastroenterology and Hepatology, Paediatric Surgery

    المصدر: The lancet. Gastroenterology & hepatology, 5(10), 900-907. HANLEY & BELFUS-ELSEVIER INC
    LIR!C study group 2020, ' Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease : retrospective long-term follow-up of the LIR!C trial ', The Lancet Gastroenterology and Hepatology, vol. 5, no. 10, pp. 900-907 . https://doi.org/10.1016/S2468-1253(20)30117-5
    The Lancet Gastroenterology and Hepatology, 5(10), 900-907. Elsevier Ltd
    lancet. Gastroenterology & hepatology, 5(10), 900-907. Elsevier Limited

  4. 4

    المصدر: Medicina Interna; Vol. 28 N.º 4 (2021): Outubro / Dezembro
    Repositório Científico de Acesso Aberto de Portugal
    Repositório Científico de Acesso Aberto de Portugal (RCAAP)
    instacron:RCAAP
    Medicina Interna v.28 n.4 2021

    وصف الملف: application/pdf; text/html

  5. 5

    المساهمون: Rheumatology, AII - Inflammatory diseases, Epidemiology and Data Science, APH - Methodology, Psychology, Health & Technology, Clinical Immunology and Rheumatology, AMS - Ageing & Morbidty, AMS - Amsterdam Movement Sciences, AMS - Musculoskeletal Health, Public Health Sciences, RS: CAPHRI - R2 - Creating Value-Based Health Care, MUMC+: KIO Kemta (9)

    المصدر: Annals of the Rheumatic Diseases, 79, 6, pp. 685-699
    Smolen, J S, Landewé, R B M, Bijlsma, J W J, Burmester, G R, Dougados, M, Kerschbaumer, A, McInnes, I B, Sepriano, A, Van Vollenhoven, R F, De Wit, M, Aletaha, D, Aringer, M, Askling, J, Balsa, A, Boers, M, Den Broeder, A A, Buch, M H, Buttgereit, F, Caporali, R, Cardiel, M H, De Cock, D, Codreanu, C, Cutolo, M, Edwards, C J, Van Eijk-Hustings, Y, Emery, P, Finckh, A, Gossec, L, Gottenberg, J E, Hetland, M L, Huizinga, T W J, Koloumas, M, Li, Z, Mariette, X, Müller-Ladner, U, Mysler, E F, Da Silva, J A P, Poór, G, Pope, J E, Rubbert-Roth, A, Ruyssen-Witrand, A, Saag, K G, Strangfeld, A, Takeuchi, T, Voshaar, M, Westhovens, R & Van Der Heijde, D 2020, ' EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs : 2019 update ', Annals of the Rheumatic Diseases, vol. 79, no. 6, pp. S685-S699 . https://doi.org/10.1136/annrheumdis-2019-216655
    Annals of the Rheumatic Diseases, 79(6), S685-S699. BMJ Publishing Group
    Annals of the rheumatic diseases, 79(6), S685-S699. BMJ
    Annals of the rheumatic diseases, 79(6), S685-S699. BMJ Publishing Group
    Annals of the Rheumatic Diseases, 79, 685-699
    Annals of the Rheumatic Diseases, Vol. 79, No 6 (2020) pp. 685-699

    مصطلحات موضوعية: rheumatoid arthritis, Synthetic Drugs, DMARDs (biologic), Arthritis, Rheumatoid, 0302 clinical medicine, RHEUMATOLOGY/EUROPEAN LEAGUE, Immunology and Allergy, Biological Products/economics, 030212 general & internal medicine, INTERLEUKIN-6 RECEPTOR INHIBITION, skin and connective tissue diseases, Societies, Medical, ddc:616, treatment, DOSE GLUCOCORTICOID THERAPY, economic evaluations, Antirheumatic Agents/economics/therapeutic use, Biological Products/economics/therapeutic use, TREATMENT STRATEGIES, Europe, TREAT-TO-TARGET, Arthritis, Rheumatoid/drug therapy, Antirheumatic Agents, Combination, CONSENSUS-BASED RECOMMENDATIONS, Drug Therapy, Combination, DMARDs (synthetic), Life Sciences & Biomedicine, musculoskeletal diseases, Consensus, Immunology, REMISSION INDUCTION, AMERICAN-COLLEGE, General Biochemistry, Genetics and Molecular Biology, Rheumatoid/drug therapy, Synthetic Drugs/economics, CERTOLIZUMAB PEGOL, 03 medical and health sciences, Drug Therapy, RAPID RADIOGRAPHIC PROGRESSION, Rheumatology, Medical, Synthetic Drugs/economics/therapeutic use, Humans, Janus Kinase Inhibitors, 030203 arthritis & rheumatology, Biological Products, Science & Technology, Tumor Necrosis Factor-alpha/antagonists & inhibitors, Tumor Necrosis Factor-alpha, Arthritis, Janus Kinase Inhibitors/therapeutic use, Antirheumatic Agents/economics, n/a OA procedure, Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5], Societies, Systematic Reviews as Topic

    وصف الملف: Print-Electronic; application/pdf

  6. 6

    المساهمون: UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service de gastro-entérologie, University of Zurich, Macpherson, Andrew J, Petit, Laëtitia Marie

    المصدر: Nature medicine, Vol. 25, no. 2, p. 323-336 (2019)
    Nature Medicine
    Nature Medicine, Vol. 25, No 2 (2019) pp. 323-336

  7. 7

    المصدر: Heftdal, L D, Loft, A G, Hendricks, O, Ashouri Christiansen, A, Schiøttz-Christensen, B, Arnbak, B, Jurik, A G, Østgård, R, Winding Deleuran, B, Møller, H J & Greisen, S R 2018, ' Divergent effects on macrophage biomarkers soluble CD163 and CD206 in axial spondyloarthritis ', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 78, no. 6, pp. 483-489 . https://doi.org/10.1080/00365513.2018.1500704
    Heftdal, L D, Loft, A G, Hendricks, O, Ashouri Christiansen, A, Schiøttz-Christensen, B, Arnbak, B, Jurik, A G, Østgård, R, Winding Deleuran, B, Møller, H J & Greisen, S R 2018, ' Divergent effects on macrophage biomarkers soluble CD163 and CD206 in axial spondyloarthritis ', Scandinavian Journal of Clnical and Laboratory Investigation, vol. 78, no. 6, pp. 483-489 . https://doi.org/10.1080/00365513.2018.1500704

  8. 8

    المساهمون: Other departments, Global Health

    المصدر: European respiratory journal, 46(6), 1563-1576. European Respiratory Society
    The European Respiratory Journal
    Getahun, H, Matteelli, A, Abubakar, I, Aziz, M A, Baddeley, A, Barreira, D, Den Boon, S, Borroto Gutierrez, S M, Bruchfeld, J, Burhan, E, Cavalcante, S, Cedillos, R, Chaisson, R, Chee, C B-E, Chesire, L, Corbett, E, Dara, M, Denholm, J, de Vries, G, Falzon, D, Ford, N, Gale-Rowe, M, Gilpin, C, Girardi, E, Go, U-Y, Govindasamy, D, Grant, A D, Grzemska, M, Harris, R, Horsburgh, C R, Ismayilov, A, Jaramillo, E, Kik, S, Kranzer, K, Lienhardt, C, LoBue, P, Lönnroth, K, Marks, G, Menzies, D, Migliori, G B, Mosca, D, Mukadi, Y D, Mwinga, A, Nelson, L, Nishikiori, N, Oordt-Speets, A, Rangaka, M X, Reis, A, Rotz, L, Sandgren, A, Sañé Schepisi, M, Schünemann, H J, Sharma, S K, Sotgiu, G, Stagg, H R, Sterling, T R, Tayeb, T, Uplekar, M, van der Werf, M J, Vandevelde, W, van Kessel, F, van't Hoog, A, Varma, J K, Vezhnina, N, Voniatis, C, Vonk Noordegraaf-Schouten, M, Weil, D, Weyer, K, Wilkinson, R J, Yoshiyama, T, Zellweger, J P & Raviglione, M 2015, ' Management of latent Mycobacterium tuberculosis infection : WHO guidelines for low tuberculosis burden countries ', European Respiratory Journal, vol. 46, no. 6, pp. 1563-1576 . https://doi.org/10.1183/13993003.01245-2015

    مصطلحات موضوعية: Gerontology, Thoracic, Antitubercular Agents, Antirheumatic Agents/therapeutic use, HIV Infections, Comorbidity, Kidney Failure, Drug Users, Substance-Related Disorders/epidemiology, Mass Screening, Medicine, Chronic, Human Biology & Physiology, Evidence-Based Medicine, Latent tuberculosis, biology, Coinfection, Medicine (all), Disease Management, Homeless Persons, Antirheumatic Agents, Emigrants and Immigrants, Health Personnel, Humans, Interferon-gamma Release Tests, Isoniazid, Kidney Failure, Chronic, Latent Tuberculosis, Practice Guidelines as Topic, Prisoners, Public Health, Radiography, Thoracic, Renal Dialysis, Rifampin, Risk Assessment, Silicosis, Substance-Related Disorders, Transplant Recipients, Tuberculin Test, Tumor Necrosis Factor-alpha, World Health Organization, Pulmonary and Respiratory Medicine, HIV Infections/epidemiology, Ill-Housed Persons, Latent Tuberculosis/diagnosis, Perspectives, medicine.drug, Model organisms, medicine.medical_specialty, Tuberculosis, Isoniazid/therapeutic use, Antitubercular Agents/therapeutic use, Immunology, Tuberculin, Infectious Disease, Mycobacterium tuberculosis, Silicosis/epidemiology, Internal medicine, Coinfection/epidemiology, Kidney Failure, Chronic/epidemiology, Mass screening, Tumor Necrosis Factor-alpha/antagonists & inhibitors, business.industry, FOS: Clinical medicine, Rifampin/analogs & derivatives, medicine.disease, biology.organism_classification, bacterial infections and mycoses, Rifapentine, Radiography, Transplantation, business, Rifampicin

    وصف الملف: application/pdf

  9. 9
  10. 10

    المساهمون: Clinical Immunology and Rheumatology, AII - Inflammatory diseases

    المصدر: Annals of the Rheumatic Diseases, 79(6), 700-712. BMJ PUBLISHING GROUP
    Annals of the rheumatic diseases, 79(6), S700-S712. BMJ Publishing Group
    Gossec, L, Baraliakos, X, Kerschbaumer, A, de Wit, M, McInnes, I, Dougados, M, Primdahl, J, McGonagle, D G, Aletaha, D, Balanescu, A, Balint, P V, Bertheussen, H, Boehncke, W-H, Burmester, G R, Canete, J D, Damjanov, N S, Kragstrup, T W, Kvien, T K, Landewé, R B M, Lories, R J U, Marzo-Ortega, H, Poddubnyy, D, Rodrigues Manica, S A, Schett, G, Veale, D J, Van den Bosch, F E, van der Heijde, D & Smolen, J S 2020, ' EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2019 update ', Annals of the Rheumatic Diseases, vol. 79, no. 6, pp. 700-712 . https://doi.org/10.1136/annrheumdis-2020-217159
    Annals of the Rheumatic Diseases
    Gossec, L, Baraliakos, X, Kerschbaumer, A, de Wit, M, McInnes, I, Dougados, M, Primdahl, J, McGonagle, D G, Aletaha, D, Balanescu, A, Balint, P V, Bertheussen, H, Boehncke, W H, Burmester, G R, Canete, J D, Damjanov, N S, Kragstrup, T W, Kvien, T K, Landewé, R B M, Lories, R J U, Marzo-Ortega, H, Poddubnyy, D, Rodrigues Manica, S A, Schett, G, Veale, D J, Van den Bosch, F E, van der Heijde, D & Smolen, J S 2020, ' EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2019 update ', Annals of the rheumatic diseases, vol. 79, no. 6, pp. 700-712 . https://doi.org/10.1136/annrheumdis-2020-217159
    ANNALS OF THE RHEUMATIC DISEASES
    Annals of the Rheumatic Diseases, Vol. 79, No 6 (2020) pp. 700-712

    مصطلحات موضوعية: Glucocorticoids/therapeutic use, Interleukin-17/antagonists & inhibitors, Synthetic Drugs, medicine.medical_treatment, Consensus Development Conferences as Topic, Anti-Inflammatory Agents, Arthritis, DMARDs (biologic), urologic and male genital diseases, PLACEBO-CONTROLLED TRIAL, DISEASE-ACTIVITY, Interleukin-23, DOUBLE-BLIND, 0302 clinical medicine, CLINICAL CHARACTERISTICS, Medicine and Health Sciences, Immunology and Allergy, 030212 general & internal medicine, skin and connective tissue diseases, Societies, Medical, MODIFYING ANTIRHEUMATIC DRUG, ddc:616, psoriatic arthritis, Oligoarthritis, treatment, Anti-Inflammatory Agents, Non-Steroidal, Interleukin-17, ANKYLOSING-SPONDYLITIS, RANDOMIZED CONTROLLED-TRIAL, Interleukin-12, Shared, TNF inhibitor, Europe, MANIFESTATIONS, EXTRAARTICULAR, Rheumatoid arthritis, Psoriatic/drug therapy, Polyarthritis, Synthetic Drugs/therapeutic use, Biological Products/therapeutic use, Life Sciences & Biomedicine, musculoskeletal diseases, Non-Steroidal/therapeutic use, medicine.medical_specialty, Consensus, education, Decision Making, Immunology, Context (language use), Phosphodiesterase 4 Inhibitors/therapeutic use, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, Psoriatic arthritis, Rheumatology, Medical, medicine, Humans, Janus Kinase Inhibitors, Intensive care medicine, Glucocorticoids, 030203 arthritis & rheumatology, Biological Products, Science & Technology, Tumor Necrosis Factor-alpha/antagonists & inhibitors, business.industry, Tumor Necrosis Factor-alpha, Interleukin-12/antagonists & inhibitors, Janus Kinase Inhibitors/therapeutic use, Arthritis, Psoriatic, Biology and Life Sciences, Evidence-based medicine, Interleukin-23/antagonists & inhibitors, Recommendation, medicine.disease, PHASE-III, RHEUMATOID-ARTHRITIS, EXTRAARTICULAR MANIFESTATIONS, Phosphodiesterase 4 Inhibitors, Societies, business, Decision Making, Shared, Systematic Reviews as Topic

    وصف الملف: application/pdf; Print